294 related articles for article (PubMed ID: 12665971)
1. Polymorphisms in the MLL breakpoint cluster region (BCR).
Echlin-Bell DR; Smith LL; Li L; Strissel PL; Strick R; Gupta V; Banerjee J; Larson R; Relling MV; Raimondi SC; Hayashi Y; Taki T; Zeleznik-Le N; Rowley JD
Hum Genet; 2003 Jul; 113(1):80-91. PubMed ID: 12665971
[TBL] [Abstract][Full Text] [Related]
2. Identification of complex genomic breakpoint junctions in the t(9;11) MLL-AF9 fusion gene in acute leukemia.
Super HG; Strissel PL; Sobulo OM; Burian D; Reshmi SC; Roe B; Zeleznik-Le NJ; Diaz MO; Rowley JD
Genes Chromosomes Cancer; 1997 Oct; 20(2):185-95. PubMed ID: 9331569
[TBL] [Abstract][Full Text] [Related]
3. Analysis of t(9;11) chromosomal breakpoint sequences in childhood acute leukemia: almost identical MLL breakpoints in therapy-related AML after treatment without etoposides.
Langer T; Metzler M; Reinhardt D; Viehmann S; Borkhardt A; Reichel M; Stanulla M; Schrappe M; Creutzig U; Ritter J; Leis T; Jacobs U; Harbott J; Beck JD; Rascher W; Repp R
Genes Chromosomes Cancer; 2003 Apr; 36(4):393-401. PubMed ID: 12619163
[TBL] [Abstract][Full Text] [Related]
4. Distribution of 11q23 breakpoints within the MLL breakpoint cluster region in de novo acute leukemia and in treatment-related acute myeloid leukemia: correlation with scaffold attachment regions and topoisomerase II consensus binding sites.
Broeker PL; Super HG; Thirman MJ; Pomykala H; Yonebayashi Y; Tanabe S; Zeleznik-Le N; Rowley JD
Blood; 1996 Mar; 87(5):1912-22. PubMed ID: 8634439
[TBL] [Abstract][Full Text] [Related]
5. MLL genomic breakpoint distribution within the breakpoint cluster region in de novo leukemia in children.
Felix CA; Hosler MR; Slater DJ; Parker RI; Masterson M; Whitlock JA; Rebbeck TR; Nowell PC; Lange BJ
J Pediatr Hematol Oncol; 1998; 20(4):299-308. PubMed ID: 9703001
[TBL] [Abstract][Full Text] [Related]
6. An in vivo topoisomerase II cleavage site and a DNase I hypersensitive site colocalize near exon 9 in the MLL breakpoint cluster region.
Strissel PL; Strick R; Rowley JD; Zeleznik-Le NJ
Blood; 1998 Nov; 92(10):3793-803. PubMed ID: 9808573
[TBL] [Abstract][Full Text] [Related]
7. Rearrangements of the MLL gene in therapy-related acute myeloid leukemia in patients previously treated with agents targeting DNA-topoisomerase II.
Super HJ; McCabe NR; Thirman MJ; Larson RA; Le Beau MM; Pedersen-Bjergaard J; Philip P; Diaz MO; Rowley JD
Blood; 1993 Dec; 82(12):3705-11. PubMed ID: 8260707
[TBL] [Abstract][Full Text] [Related]
8. All patients with the T(11;16)(q23;p13.3) that involves MLL and CBP have treatment-related hematologic disorders.
Rowley JD; Reshmi S; Sobulo O; Musvee T; Anastasi J; Raimondi S; Schneider NR; Barredo JC; Cantu ES; Schlegelberger B; Behm F; Doggett NA; Borrow J; Zeleznik-Le N
Blood; 1997 Jul; 90(2):535-41. PubMed ID: 9226152
[TBL] [Abstract][Full Text] [Related]
9. Clinical and biological characteristics of adult de novo and secondary acute myeloid leukemia with balanced 11q23 chromosomal anomaly or MLL gene rearrangement compared to cases with unbalanced 11q23 anomaly: confirmation of the existence of different entities with 11q23 breakpoint.
Archimbaud E; Charrin C; Magaud JP; Campos L; Thomas X; Fière D; Rimokh R
Leukemia; 1998 Jan; 12(1):25-33. PubMed ID: 9436917
[TBL] [Abstract][Full Text] [Related]
10. MLL-SEPTIN6 fusion recurs in novel translocation of chromosomes 3, X, and 11 in infant acute myelomonocytic leukaemia and in t(X;11) in infant acute myeloid leukaemia, and MLL genomic breakpoint in complex MLL-SEPTIN6 rearrangement is a DNA topoisomerase II cleavage site.
Slater DJ; Hilgenfeld E; Rappaport EF; Shah N; Meek RG; Williams WR; Lovett BD; Osheroff N; Autar RS; Ried T; Felix CA
Oncogene; 2002 Jul; 21(30):4706-14. PubMed ID: 12096348
[TBL] [Abstract][Full Text] [Related]
11. Secondary leukemias induced by topoisomerase-targeted drugs.
Felix CA
Biochim Biophys Acta; 1998 Oct; 1400(1-3):233-55. PubMed ID: 9748598
[TBL] [Abstract][Full Text] [Related]
12. HRX gene rearrangement in secondary acute lymphoblastic leukemia.
Kobayashi Y; Hayashi Y; Ozawa K; Asano S
Leuk Lymphoma; 1995 May; 17(5-6):391-9. PubMed ID: 7549829
[TBL] [Abstract][Full Text] [Related]
13. ALL-1 gene rearrangements in DNA topoisomerase II inhibitor-related leukemia in children.
Felix CA; Hosler MR; Winick NJ; Masterson M; Wilson AE; Lange BJ
Blood; 1995 Jun; 85(11):3250-6. PubMed ID: 7756657
[TBL] [Abstract][Full Text] [Related]
14. Dietary bioflavonoids induce cleavage in the MLL gene and may contribute to infant leukemia.
Strick R; Strissel PL; Borgers S; Smith SL; Rowley JD
Proc Natl Acad Sci U S A; 2000 Apr; 97(9):4790-5. PubMed ID: 10758153
[TBL] [Abstract][Full Text] [Related]
15. Molecular analysis of 13 cases of MLL/11q23 secondary acute leukemia and identification of topoisomerase II consensus-binding sequences near the chromosomal breakpoint of a secondary leukemia with the t(4;11).
Domer PH; Head DR; Renganathan N; Raimondi SC; Yang E; Atlas M
Leukemia; 1995 Aug; 9(8):1305-12. PubMed ID: 7643617
[TBL] [Abstract][Full Text] [Related]
16. A novel chromosomal inversion at 11q23 in infant acute myeloid leukemia fuses MLL to CALM, a gene that encodes a clathrin assembly protein.
Wechsler DS; Engstrom LD; Alexander BM; Motto DG; Roulston D
Genes Chromosomes Cancer; 2003 Jan; 36(1):26-36. PubMed ID: 12461747
[TBL] [Abstract][Full Text] [Related]
17. Rearrangements involving chromosome band 11Q23 in acute leukaemia.
Rowley JD
Semin Cancer Biol; 1993 Dec; 4(6):377-85. PubMed ID: 8142623
[TBL] [Abstract][Full Text] [Related]
18. Seminars from the University of Minnesota. Chromosome translocations: dangerous liaisons.
Rowley JD
J Lab Clin Med; 1998 Oct; 132(4):244-50. PubMed ID: 9794694
[TBL] [Abstract][Full Text] [Related]
19. Concurrent translocations of MLL and CBFA2 (AML1) genes with new partner breakpoints in a child with secondary myelodysplastic syndrome after treatment of acute lymphoblastic leukemia.
Mathew S; Head D; Rubnitz JE; Raimondi SC
Genes Chromosomes Cancer; 2000 Jun; 28(2):227-32. PubMed ID: 10825008
[TBL] [Abstract][Full Text] [Related]
20. Near-precise interchromosomal recombination and functional DNA topoisomerase II cleavage sites at MLL and AF-4 genomic breakpoints in treatment-related acute lymphoblastic leukemia with t(4;11) translocation.
Lovett BD; Lo Nigro L; Rappaport EF; Blair IA; Osheroff N; Zheng N; Megonigal MD; Williams WR; Nowell PC; Felix CA
Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9802-7. PubMed ID: 11493704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
